Targeting specific fungi or fungal metabolites may offer novel therapeutic strategies for MASLD
Szrok-Jurga S, Czumaj A, Turyn J, Hebanowska A, Swierczynski J, Sledzinski T, Stelmanska E
In reality, their skin never had a chance to adjust
Patients with a personal or strong family history of certain cancers are not automatically excluded from Epithalon therapy, but the risk-benefit discussion is mandatory before protocol initiation
De par ses actions antioxydantes , cette molcule participe lutter contre les cataractes et le glaucome
Furthermore, the EAE mouse with selective microglial C1q deletion or treated with C1q inhibitor showed reduced levels of microgliosis and signature markers of DAM and MIMS, although without improvement of the clinical score or change in the disease onset date